seed
Stage
1
Investors
About
OraLiva develops an automated, AI-powered microfluidic platform that detects early oral cancer by analyzing brush-biopsied cells with over 95% accuracy, providing a minimally invasive and reimbursable diagnostic tool for healthcare providers.
Explore OraLiva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.